{"name":"Valinor Pharma LLC","slug":"valinor-pharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"non-PAMORA","genericName":"non-PAMORA","slug":"non-pamora","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"non-PAMORA","genericName":"non-PAMORA","slug":"non-pamora","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOSkd6b3A1WmVTZTVSMlc3Ry1BR2owTXVPYzBLaEs4NGFxMjJtU0F2ckFRZFJrQVhuTFZFal9WSml6YU55aDd1TUg5WEdkYTlpY01VcFp6T1hjV1B3X1ZrMGV4ZlRnNFprUU5XMm9VNk5rLXEwYmtJTlFqOTJlS2FscERnTENiQzcyMkliNGZmSFJTWkJvM09vZFlfMEQ?oc=5","date":"2026-04-03","type":"pipeline","source":"openPR.com","summary":"Global Factors Driving the Rapid Evolution of the Pain Patch Market - openPR.com","headline":"Global Factors Driving the Rapid Evolution of the Pain Patch Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE51b2FzeVpac0ZfUjdKaC1peEpNWHZLV1gxb2ttVm9OYUo0RVFVY2wxVFY4V0hlTnVrdW02YXlxVTJ5U1Y2TDRjNjNXSHlkWW1YOVhsVU1WQ0FFLUUwYXhRQ290VdIBaEFVX3lxTE4td2pCNXpBdTdnRDZ4VUd0SUNlLXJrQllOeWQ3THRwZ1dxdnM5d3VfWmZNUmhIZGpMVjJYTEJZb0JETFc5dFVSTnRsTTVnTnRmUHJBbnFoX055cExIdG1xdHJ3SUR3QXYz?oc=5","date":"2025-12-17","type":"trial","source":"Pulse 2.0","summary":"Valinor: $13 Million Seed Funding Raised To Boost Clinical Trial Success With Multimodal Machine Learning - Pulse 2.0","headline":"Valinor: $13 Million Seed Funding Raised To Boost Clinical Trial Success With Multimodal Machine Learning - Pulse 2.0","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOcWFIaUx0MUJsNnhDbHZKWVFrSjM2Tk94NWlyUTFsNkdhaFpVMmhwQnRpTnlWUEs0bEl0aWRkX3A0XzJ4cjBmWFRiRGdnb29wbE1CNHVfU3JYYnJ2eFlPa21FWGdjMTh1XzRaa01icjdfUDZtSUNmS3lCR3c4emJXZnVMRThwaGpN?oc=5","date":"2024-08-22","type":"pipeline","source":"Private Equity Stakeholder Project PESP","summary":"Private Equity Healthcare Acquisitions – July 2024 - Private Equity Stakeholder Project PESP","headline":"Private Equity Healthcare Acquisitions – July 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPLUZNdm9zS012dVg5YjBXamtLdXoxVllQcWVvLVpyTjFsZmNoc3k2dzdGeklDd1B1WGxtb1hSNFF3ckdaQldMSDN1VGhZLXV4S0lGNHF3ZzNkYkhjNWFlNnFVMk8tODUyWDBvaDFiNC1OYkZpd2VLbGI1WVR4d292Sy0zN2Z6LWpBYmlkbGdodkgyMkVmeEVHakx1SF9KZTRlQzVZS0dB?oc=5","date":"2024-07-25","type":"pipeline","source":"The Business Journals","summary":"Raleigh pharma gets cash jolt at critical time - The Business Journals","headline":"Raleigh pharma gets cash jolt at critical time","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOWThmZUNlWGhIMF8zbXFJTmk5ZHFuWUxxbmJrQjljRmlLS0hTN21RanlOUnN5MFFBbXF2VU5IY3h4eFR2Z2cyLTdkSFR3QkRrUTNEb283aFJDV1hoUFV3VkM0WWhmUGdqQ2pNVWI0cTlMZDhYazFTRExKUWoxNVJxeTFhQjFrYU1uTXpWQ3ZlZVZSSUxxX3hudGF2OUx5UnhWY1FDazdHbUJ4Rms?oc=5","date":"2024-07-22","type":"pipeline","source":"Fierce Pharma","summary":"Grünenthal continues US growth push with $250M acquisition of Valinor Pharma - Fierce Pharma","headline":"Grünenthal continues US growth push with $250M acquisition of Valinor Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOMzI4MXFXYy1YLVJCWC1ZYTFBR3Y4NTB4MTVVanlYWjRMcEhoNndacHhacUtINkgyR3BjUTlfcGZnV3ktTGpoQ2JzLUtaOS1ER240cVNzRExUWU5KWjlpNTFlQUlZWjhRUHAtMjNnWjkxODFzNFhMYk1sOXZqTTJsUTVrRDlIakhxRWdfUmtsaUZ2ZDF3S09FaHhnZFFRRU0xY29aZGJEcmtSOThtUEFhYkRsdnZVSDA2cEFEQ0twZEZveGxWU2djY0ZCdXpwNWFHR01wOVJDZnF5Y3pLZEFv?oc=5","date":"2024-07-22","type":"pipeline","source":"PR Newswire","summary":"RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien - PR Newswire","headline":"RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPbldHOFhxTF82M0hKY3d0STNIa1dsTWoxNUtBcFNZd3NWMHFIb2xzd0dRTkc2dnF4U28yWmNYLXN6ekVXa3h5NFJWV3A3OFlLRWRIb3kxSy16QURrY0tBUTRUUzc4S2premJjR0czc2U4ZmpPX1JhZU9ITTltLW1kRy02UXEtZVRGRmNSNHRHVGI0emE3ZmdBa0F1TnRpS3IzamtlQ25SNVA3SmFENGZCR2UyV1d4cGNielRralFzaEEwRDNmSmFhVGhvVjM0bXlmb2ZzeWZsYV9EMzBEaUpxOGpJTXpWeHM1Y2tGSzdIQ3NjUQ?oc=5","date":"2024-07-22","type":"deal","source":"Via Ritzau","summary":"Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik® - Via Ritzau","headline":"Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}